Neonatal meningitis: Can we do better?

Advances in Experimental Medicine and Biology

Volumn 719, Issue , 2011, Pages 11-24

  Heath, Paul T ^a   Okike, Ifeanyichukwu O ^a   Oeser, Clarissa ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; AMPICILLIN; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; CORTICOSTEROID; DAPTOMYCIN; DEXAMETHASONE; GENTAMICIN; GLYCEROL; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; MEROPENEM; PNEUMOCOCCUS VACCINE; RIFAMPICIN; STREPTOMYCIN; SULFONAMIDE; VANCOMYCIN;

ADJUVANT THERAPY; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; BLOOD CULTURE; CEREBRAL PALSY; CEREBROSPINAL FLUID CULTURE; CLINICAL FEATURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONGENITAL HYDROCEPHALUS; DELAYED DIAGNOSIS; DEVELOPED COUNTRY; DEVELOPMENTAL DISORDER; DISEASE SEVERITY; DISEASE SURVEILLANCE; ELECTROENCEPHALOGRAPHY; ESCHERICHIA COLI; FLUID RESUSCITATION; GRAM NEGATIVE BACTERIUM; HUMAN; HYPOTHERMIA; IMMUNIZATION; IMMUNOTHERAPY; INCIDENCE; LETHARGY; LISTERIOSIS; LOW BIRTH WEIGHT; LUMBAR PUNCTURE; NEONATAL MENINGITIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEUTROPENIA; NEWBORN MORBIDITY; NEWBORN MORTALITY; NONHUMAN; PERCEPTION DEAFNESS; PNEUMOCOCCAL MENINGITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SEIZURE; SEPSIS; STREPTOCOCCUS AGALACTIAE; VISUAL IMPAIRMENT; VOMITING;

HUMANS; INFANT, NEWBORN; MENINGITIS;

EID: 83455210001     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-0204-6_2     Document Type: Article

References (67)

1. Goldacre MJ. Acute bacterial meningitis in childhood. Lancet. 1976;1:701.
2. de Louvois J, Blackbourn J, Hurley R, Harvey D. Infantile meningitis in England and Wales: a two year study. Arch Dis Child. 1991;66:603-7.
3. Hristeva L, Booy R, Bowler I, Wilkinson AR. Prospective surveillance of neonatal meningitis. Arch Dis Child. 1993;69:14-8. (Pubitemid 23232974)
4. Holt DE, Halket S, de Louvois J, Harvey D. Neonatal meningitis in England and Wales: 10 years on. Arch Dis Child Fetal Neonatal Ed. 2001;84:F85-9. (Pubitemid 32250847)
5. Goldacre MJ. Neonatal meningitis. Postgrad Med J. 1977;53:607-9. (Pubitemid 8208757)
6. Persson E, Trollfors B, Brandberg LL, Tessin I. Septicaemia and meningitis in neonates and during early infancy in the Goteborg area of Sweden. Acta Paediatr. 2002;91:1087-92. (Pubitemid 35204002)
7. Thaver D, Zaidi AK. Burden of neonatal infections in developing countries: a review of evidence from communitybased studies. Pediatr Infect Dis J. 2009;28:S3-9.
8. Synnott MB, Morse DL, Hall SM. Neonatal meningitis in England and Wales: a review of routine national data. Arch Dis Child. 1994;71:F75-80. (Pubitemid 24302243)
9. Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis. 1990;162:1316-23.
10. Francis BM, Gilbert GL. Survey of neonatal meningitis in Australia: 1987-1989. Med J Aust. 1992;156:240-3.
11. Levy C, de La Rocque F, Cohen R. [Epidemiology of pediatric bacterial meningitis in France]. Med Mal Infect. 2009;39:419-31.
12. Kalliola S, Vuopio-Varkila J, Takala AK, Eskola J. Neonatal group B streptococcal disease in Finland: a ten-year nationwide study. Pediatr Infect Dis J. 1999;18:806-10. (Pubitemid 29428537)
13. Fluegge K, Siedler A, Heinrich B, Schulte-Moenting J, Moennig MJ, Bartels DB, et al. Incidence and clinical presentation of invasive neonatal group B streptococcal infections in Germany. Pediatrics. 2006;117: e1139-45. (Pubitemid 46071210)
14. Neto MT. Group B streptococcal disease in Portuguese infants younger than 90 days. Arch Dis Child Fetal Neonatal Ed. 2008;93:F90-3. (Pubitemid 352038495)
15. Heath PGT, Balfour G, Weisner AM, Efstratiou A, Lamagni TL, Tighe H, et al. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet. 2004;363:292-4. (Pubitemid 38142414)
16. Mulder CJ, Zanen HC. A study of 280 cases of neonatal meningitis in The Netherlands. J Infect. 1984;9:177-84. (Pubitemid 15118436)
17. Franco SM, Cornelius VE, Andrews BF. Long-term outcome of neonatal meningitis. Am J Dis Child. 1992;146:567-71.
18. Bedford H, de Louvois J, Halket S, Peckham C, Hurley R, Harvey D. Meningitis in infancy in England and Wales: follow up at age 5 years. BMJ. 2001;323:533-6. (Pubitemid 32835570)
19. de Louvois J, Halket S, Harvey D. Neonatal meningitis in England and Wales: sequelae at 5 years of age. Eur J Pediatr. 2005;164:730-4. (Pubitemid 41609472)
20. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA. 2004;292: 2357-65. (Pubitemid 39491920)
21. Palazzi D, Klein J, C B. Bacterial sepsis and meningitis. In: Remington JS, Klein J, editors. Infectious Disease of the Fetus and Newborn Infants 6th ed. Philadelphia: Elsevier Saunders; 2006. p. 247-95.
22. Thompson MJ, Ninis N, Perera R, Mayon-White R, Phillips C, Bailey L, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006;367:397-403. (Pubitemid 43184259)
23. Holt DE. Neonatal meningitis in England and Wales: 10 years on. Archives of Disease in Childhood-Fetal and Neonatal Edition. 2001;84:85F-89.
24. May M. Early onset neonatal meningitis in Australia and New Zealand, 1992-2002. Archives of Disease in Childhood-Fetal and Neonatal Edition. 2005;90:F324-f7. (Pubitemid 40933396)
25. Heath PT, Balfour GF, Tighe H, Verlander NQ, Lamagni TL, Efstratiou A. Group B streptococcal disease in infants: a case control study. Archives of Disease in Childhood. 2009;94:674-80.
26. Merenstein GB. Neonatal sepsis. Current Opinion in Infectious Diseases. 1992;5:553-7.
27. Johnson CE, Whitwell JK, Pethe K, Saxena K, Super DM. Term newborns who are at risk for sepsis: are lumbar punctures necessary? Pediatrics. 1997;99:E10.
28. Fielkow S, Reuter S, Gotoff SP. Cerebrospinal fluid examination in symptom-free infants with risk factors for infection. J Pediatr. 1991;119:971-3.
29. Wiswell TE, Baumgart S, Gannon CM, Spitzer AR. No lumbar puncture in the evaluation for early neonatal sepsis: will meningitis be missed? Pediatrics. 1995;95:803-6.
30. Visser VE, Hall RT. Lumbar puncture in the evaluation of suspected neonatal sepsis. J Pediatr. 1980;96:1063-7. (Pubitemid 10068851)
31. Garges HP. Neonatal Meningitis: What Is the Correlation Among Cerebrospinal Fluid Cultures, Blood Cultures, and Cerebrospinal Fluid Parameters? Pediatrics. 2006;117:1094-100. (Pubitemid 46071500)
32. Ansong AK, Smith PB, Benjamin DK, Clark RH, Li JS, Cotten CM, et al. Group B streptococcal meningitis: cerebrospinal fluid parameters in the era of intrapartum antibiotic prophylaxis. Early Hum Dev. 2009;85:S5-7.
33. Vergnano S, Embleton N, Collinson A, Menson E, Russell BA, Heath P. Missed opportunities for preventing group B streptococcus infection. Archives of Disease in Childhood-Fetal and Neonatal Edition 2009;95:F72-F3.
34. Kestenbaum LA, Ebberson J, Zorc JJ, Hodinka RL, Shah SS. Defining Cerebrospinal Fluid White Blood Cell Count Reference Values in Neonates and Young Infants. Pediatrics. 2010;125:257-64.
35. Sarman G, Moise AA, Edwards MS. Meningeal inflammation in neonatal gram-negative bacteremia. Pediatr Infect Dis J. 1995;14:701-4.
36. Nigrovic LE, Malley R, Macias CG, Kanegaye JT, Moro-Sutherland DM, Schremmer RD, et al. Effect of Antibiotic Pretreatment on Cerebrospinal Fluid Profiles of Children With Bacterial Meningitis. Pediatrics. 2008;122:726-30.
37. Chiba N, Murayama SY, Morozumi M, Nakayama E, Okada T, Iwata S, et al. Rapid detection of eight causative pathogens for the diagnosis of bacterial meningitis by real-time PCR. Journal of Infection and Chemotherapy. 2009;15:92-8.
38. Rajesh NT, Dutta S, Prasad R, Narang A. Effect of delay in analysis on neonatal cerebrospinal fluid parameters. Archives of Disease in Childhood-Fetal and Neonatal Edition. 2009;95:F25-F9.
39. Abo A, Chen L, Johnston P, Santucci K. Positioning for Lumbar Puncture in Children Evaluated by Bedside Ultrasound. Pediatrics. 2010;125:e1149-e53.
40. Heath PT. Neonatal meningitis. Archives of Disease in Childhood-Fetal and Neonatal Edition. 2003;88:173 F-8.
41. Millar M, Philpott A, Wilks M, Whiley A, Warwick S, Hennessy E, et al. Colonization and persistence of antibiotic-resistant Enterobacteriaceae strains in infants nursed in two neonatal intensive care units in East London, United Kingdom. J Clin Microbiol. 2008;46:560-7. (Pubitemid 351231302)
42. Tiskumara R, Fakharee SH, Liu CQ, Nuntnarumit P, Lui KM, Hammoud M, et al. Neonatal infections in Asia. Archives of Disease in Childhood-Fetal and Neonatal Edition. 2009;94:F144-F8.
43. Mitja O, Pigrau C, Ruiz I, Vidal X, Almirante B, Planes AM, et al. Predictors of mortality and impact of aminoglycosides on outcome in listeriosis in a retrospective cohort study. J Antimicrob Chemother. 2009;64:416-23.
44. Klinger G, Chin CN, Beyene J, Perlman M. Predicting the outcome of neonatal bacterial meningitis. Pediatrics. 2000;106:477-82. (Pubitemid 30664131)
45. Fernando AM, Heath PT, Menson EN. Antimicrobial policies in the neonatal units of the United Kingdom and Republic of Ireland. J Antimicrob Chemother. 2008;61:743-5. (Pubitemid 351321155)
46. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368-77.
47. Carcillo JA, Davis AL, Zaritsky A. Role of early fluid resuscitation in pediatric septic shock. JAMA. 1991;266:1242-5.
48. Han YY, Carcillo JA, Dragotta MA, Bills DM, Watson RS, Westerman ME, et al. Early reversal of pediatricneonatal septic shock by community physicians is associated with improved outcome. Pediatrics. 2003;112:793-9. (Pubitemid 37248685)
49. Nau R, Wellmer A, Soto A, Koch K, Schneider O, Schmidt H, et al. Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis. J Infect Dis. 1999;179:1557-60. (Pubitemid 29246610)
50. Grandgirard D, Oberson K, Buhlmann A, Gaumann R, Leib SL. Attenuation of cerebrospinal fluid inflammation by the nonbacteriolytic antibiotic daptomycin versus that by ceftriaxone in experimental pneumococcal meningitis. Antimicrob Agents Chemother. 2010;54:1323-6.
51. McCracken GH, Jr., Mize SG. A controlled study of intrathecal antibiotic therapy in gram-negative enteric meningitis of infancy. Report of the neonatal meningitis cooperative study group. J Pediatr. 1976;89:66-72.
52. McCracken GH, Jr., Mize SG, Threlkeld N. Intraventricular gentamicin therapy in gram-negative bacillary meningitis of infancy. Report of the Second Neonatal Meningitis Cooperative Study Group. Lancet. 1980;1:787-91.
53. Ohlsson A, Lacy JB. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database Syst Rev. 2004:CD001239.
54. http://www.npeu.ox.ac.uk/inis.
55. Bedford Russell AR, Emmerson AJ, Wilkinson N, Chant T, Sweet DG, Halliday HL, et al. A trial of recombinant human granulocyte colony stimulating factor for the treatment of very low birthweight infants with presumed sepsis and neutropenia. Arch Dis Child Fetal Neonatal Ed. 2001;84:F172-6. (Pubitemid 32411255)
56. Carr R, Brocklehurst P, Dore CJ, Modi N. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial. Lancet. 2009;373:226-33.
57. Yu JS, Grauaug A. Purulent Meningitis in the Neonatal Period. Arch Dis Child. 1963;38:391-6.
58. Daoud AS, Batieha A, Al-Sheyyab M, Abuekteish F, Obeidat A, Mahafza T. Lack of effectiveness of dexamethasone in neonatal bacterial meningitis. Eur J Pediatr. 1999;158:230-3. (Pubitemid 29144026)
59. Peltola H, Roine I, Fernandez J, Zavala I, Ayala SG, Mata AG, et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebocontrolled trial. Clin Infect Dis. 2007;45:1277-86. (Pubitemid 351411900)
60. Baker CJ, Rench MA, McInnes P. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine. 2003;21:3468-72. (Pubitemid 36792105)
61. Law MR, Palomaki G, Alfirevic Z, Gilbert R, Heath P, McCartney C, et al. The prevention of neonatal group B streptococcal disease: a report by a working group of the Medical Screening Society. J Med Screen. 2005;12:60-8. (Pubitemid 40835136)
62. Poehling KA, Talbot TR, Griffin MR, Craig AS, Whitney CG, Zell E, et al. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA. 2006;295:1668-74.
63. Slack M, et al. The 7th International Symposium on Pneumococci and Pneumococcal Diseases. Tel Aviv Israel 2010.
64. Sarff LD, Platt LH, McCracken GH, Jr. Cerebrospinal fluid evaluation in neonates: comparison of high-risk infants with and without meningitis. J Pediatr. 1976;88:473-7.
65. Portnoy JM, Olson LC. Normal cerebrospinal fluid values in children: another look. Pediatrics. 1985;75:484-7. (Pubitemid 15144660)
66. Bonadio WA, Stanco L, Bruce R, Barry D, Smith D. Reference values of normal cerebrospinal fluid composition in infants ages 0 to 8 weeks. Pediatr Infect Dis J. 1992;11:589-91.
67. Ahmed A, Hickey SM, Ehrett S, Trujillo M, Brito F, Goto C, et al. Cerebrospinal fluid values in the term neonate. Pediatr Infect Dis J. 1996;15:298-303.